HOOKIPA Achieves Research Milestone in HBV Collaboration and License Agreement with Gilead

NEXT STORY
EyePoint Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Recent Company Progress
PREV STORY
Novartis data at AAN show Mayzent’s® positive impact on cognitive processing speed, a core element of cognitive function, in people living with secondary progressive MS
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Loxo Oncology Announces Proof of Concept Clinical Data for Larotrectinib in TRK Fusion Glioblastoma Presented at the AACR Annual Meeting 2017

STAMFORD, Conn., March 31, 2017 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company ...

author_avatar
NASDAQ Market News

Cyclacel Pharmaceuticals to Release First Quarter 2017 Financial Results

BERKELEY HEIGHTS, N.J., May 05, 2017 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ...

author_avatar
NASDAQ Market News

Global Pediatric Vaccine Market 2011-2017 & 2018-2024: Approx 650 Million Vaccines Doses will be Administered by the Year 2024

Dublin, Dec. 13, 2018 (GLOBE NEWSWIRE) -- The "Pediatric Vaccine Market, Global Forecast Infants ...

author_avatar
NASDAQ Market News